← All organizations

Corza Medical GmbH

For profit

Also known as: Corza Medical GmbH

Highest phase reached

Phase 3

First clinical trial

Nov 25, 2024

First marketed drug

Apr 5, 2010

Last known activity

Nov 25, 2024

Timeline

2010s

  1. Apr 5, 2010

    human fibrin— NDA Secondary Org

Drugs by trial phase (2 distinct, 1 trials)

Phase 3 (2 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (1)

Details

Last known activity
Nov 25, 2024